Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 8Active not recruiting 3Unknown 2Withdrawn 1Terminated 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 4Lung Neoplasms 3Cholangiocarcinoma 2Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Mouth Neoplasms 1Metastatic NUT Carcinoma 1Laryngeal Neoplasms 1Klatskin Tumor 1Infiltrating Bladder Urothelial Carcinoma 1Hypopharyngeal Neoplasms 1HIV Infections 1Carcinoma 1Borderline Resectable Pancreatic Adenocarcinoma 1Bile Duct Neoplasms 1

Interventions

Radiotherapy 9Cisplatin 9Paclitaxel 6Carboplatin 6Radiation 3Biopsy 3Bevacizumab 3balstilimab 2Topotecan 2Taxes 2Nivolumab 2Ipilimumab 2Gemcitabine 2Colposcopy 2Brachytherapy 2tislelizumab 1spartalizumab 1sitravatinib 1rucaparib 1pazopanib 1infigratinib 1fludarabine 1bemarituzumab 1atezolizumab 1aldesleukin 1Watchful Waiting 1Vinorelbine 1Vaginal Smears 1Ultrasonography 1Trastuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Uterine Cervical Neoplasms × 1,2-diaminocyclohexaneplatinum II citrate × Clear all
NCT03834571 2022-06-21

Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive Women

AIDS Malignancy Consortium

Phase 2 Withdrawn
Gynecologic

Uterine Cervical Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡